Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011

Home/Uncategorized/Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011

Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011

Press Release

Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011 (Press Release Distribution) – Mar 21,2011 –

Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that it has six posters scheduled during the 2011 American College on Pharmacometrics (ACoP) meeting in San Diego, CA April 3-6, 2011. The presentations describe the use of PK/PD and physiological modeling in applications from preclinical through clinical development. Five of the posters will be presented in conjunction with Lithera, MediciNova, Pfizer, and Vitalea. The sixth poster will describe advances in the methodology of physiological modeling. After each poster has been presented at the ACoP meeting, Rosa will post links to the individual presentations at its website at 


“We are pleased to share our groundbreaking work and that of our collaborators, and are honored that all of our submitted poster presentations were accepted for inclusion in the ACoP meeting,” said Dr. Ron Beaver, Rosa’s Founder and CEO.


About Rosa
Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/ pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these approaches, Rosa’s clients collaborate in model creation and testing, retain the final model, and acquire the ability to use it and understand its implications for their drug development programs. Rosa’s staff have close to two decades of unparalleled professional experience in using drug-disease modeling and simulation (M&S) to accelerate drug development; they have covered hundreds of applications with dozens of clients. The Rosa team is unique in their breadth and depth of disease area experience, which includes metabolic and cardiovascular diseases, oncology, gastro-intestinal disease, inflammatory diseases, immune dysfunction (including rheumatoid arthritis), pain, skin conditions, respiratory disorders, and antibacterials/antivirals. For more information, visit

  Print this PR
Follow This Company On
No Image.
Contact Info
Rosa & Co LLC
Rebecca Baillie

Disclaimer: We accept no responsibility for accuracy and completeness for any information of press releases or blogs published on this site as they are submitted directly by different companies/individuals/third parties. We recommend to directly contact the poster through the contact information published on the news release NOT Please do not contact We will be unable to assist you with your inquiry. disclaims any content contained in these releases.
© 2007 – 2011 All rights reserved. Submit Press Release – Press Release Distibution Service – Free Press Release Distribution – news release distribution – press release template – press release writing – online press release distribution – seo press release service RSS
Home� |�Help Center | Press Release Format & Press Release Tips | Terms & Conditions | Editorial Guidelines | Privacy Policy | Contact Us
Use of this website signifies your agreement to the Terms of Service.
By | 2016-03-19T02:58:55+00:00 March 19th, 2016|Uncategorized|0 Comments

About the Author:

Leave A Comment